|
|
|
|
|
Prognostic value of serum miR-29 and miR-150 in patients with acute renal injury |
Wen Li-ling, Chen Jia-jia, Liang Hong-li, Fu Ming-chang |
Department of Nephrology, the Third People′s Hospital of Hainan Province, Sanya 572000, China |
|
|
Abstract Objective To evaluate the prognostic value of serum miR-29 and miR-150 in patients with acute renal injury (AKI). Methods One hundred and twenty-six cases of AKI patients admitted to the Third People′s Hospital of Hainan Province from January 2016 to December 2017, according to the survival of the 28 days were divided into the survival group (82 cases) and death group (44 cases). According to the standard of AKI staging, it was divided into AKI 1 (57 cases), AKI 2 (40 cases) and AKI 3 (29 cases). The serum levels of miR-29 and miR-150 were detected by RT-PCR, and the APACHE Ⅱ score of AKI patients was recorded. The value of miR-29 and miR-150 for evaluating the prognosis of AKI patients was analyzed by the ROC curve. Correlation analysis of serum miR-29, miR-150 level and APACHE Ⅱ score in AKI patients was done with Pearson correlation analysis. Results The expression level of miR-29 (3.14±0.96 vs. 1.93±0.42) and miR-150 (4.26±1.18 vs. 2.05±0.48) in the death group was significantly higher than that in the survival group (t=10.703, 15.106, P<0.001). Serum miR-29 (3.34±1.08 vs. 2.19±0.61 and 1.85±0.34) and miR-150 (3.92±1.15 vs. 2.80±0.91 and 2.55±0.84) expression level in AKI phase 3 were significantly higher than those in AKI phase 2 and AKI phase 1(F=5.124, 7.825, P<0.05). The ROC curve showed that the best cut-off value of serum miR-29 and miR-150 in predicting the prognosis of AKI were 2.74 and 3.83, respectively. The two combination of miR-29 and miR-150[AUC (95%CI): 0.918 (0.852~0.974)] had better sensitivity and specificity in predicting AKI the prognosis of AKI were 93.6% and 86.5%, respectively. Correlation analysis showed that miR-29 level was positively correlated with miR-150 level (r=0.806, P<0.01), miR-29 and miR-150 levels were positively correlated with APACHE Ⅱ score (r=0.634, r=0.702, P<0.01). Conclusion The expression level of serum miR-29 and miR-150 is related to the severity of patients with AKI, and may be a new target for the treatment of AKI and the prognosis of the patients.
|
|
About author:: Wen Li-ling, E-mail:13976825618@163.com |
|
|
|
[1]Lameire NH, Bagga A, Cruz D, et al. Acute kidney injury: an increasing global concern[J]. Lancet, 2013, 382(9887): 170-179.
[2]Kellum JA, Prowle JR. Paradigms of acute kidney injury in the intensive care setting[J]. Nat Rev Nephrol, 2018, 14(4): 217-230.
[3]Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges[J]. Nat Rev Drug Discov, 2014, 13(8): 622-638.
[4]Kriegel AJ, Liu Y, Fang Y, et al. The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury[J]. Physiol Genomics, 2012, 44(4): 237-244.
[5]Ranganathan P, Jayakumar C, Tang Y, et al. MicroRNA-150 deletion in mice protects kidney from myocardial infarction-induced acute kidney injury[J]. Am J Physiol Renal Physiol, 2015, 309(6): F551-F558.
[6]Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4): c179-c184.
[7]Hershkovitz-Rokah O, Geva P, Salmon-Divon M, et al. Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas[J]. Oncotarget, 2018, 9(8): 7928-7941.
[8]赵阳, 崔丽艳. microRNA作为急性肾损伤早期诊断生物标志物的研究进展[J].中华检验医学杂志, 2017, 40(8): 633-636.
[9]Xu L, Qi X, Duan S, et al. MicroRNAs: potential biomarkers for disease diagnosis[J]. Biomed Mater Eng, 2014, 24(6): 3917-3925.
[10]Wang B, Komers R, Carew R, et al. Suppression of microRNA-〖JP〗29 expression by TGF-β1 promotes collagen expression and renal fibrosis[J]. J Am Soc Nephrol, 2012, 23(2): 252-265.
[11]Zhou H, Hasni SA, Perez P, et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1[J]. J Am Soc Nephrol, 2013, 24(7): 1073-1087.
[12]Lorenzen JM, Kielstein JT, Hafer C, et al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury[J]. Clin J Am Soc Nephrol, 2011, 6(7): 1540-1546.
[13]Wang N, Zhou Y, Jiang L, et al. Urinary microRNA-10a and microRNA-30 d serve as novel, sensitive and specific biomarkers for kidney injury[J]. PLoS One, 2012, 7(12): e51140.
[14]Lorenzen JM, Kaucsar T, Schauerte C, et al. MicroRNA-24 antagonism prevents renal ischemia reperfusion injury[J]. J Am Soc Nephrol, 2014, 25(12): 2717-2729.
[15]Martino F, Lorenzen J, Schmidt J, et al. Circulating microRNAs are not eliminated by hemodialysis[J]. PLoS One, 2012, 7(6): e38269.
[16]宁莉, 魏殿军. 急性肾损伤相关miRNA的研究进展[J]. 山东医药, 2017, 57(14): 110-112.
[17]Banaei S. Novel role of microRNAs in renal ischemia reperfusion injury[J]. Ren Fail, 2015, 37(7): 1073-1079. |
|
|
|